During the past decade, Knowle House Surgery conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 8 clinical trials were completed, i.e. on average, 72.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Knowle House Surgery" #1 sponsor was "Pfizer" with 5 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Kowa Research Europe" with 3 trials sponsored, "BTG International Inc." with 1 trials sponsored and "Biota Scientific Management Pty Ltd" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Knowle House Surgery" #1 collaborator was "Brigham and Women's Hospital" with 1 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator and "Encorium" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Knowle House Surgery" are "Dyslipidemia" (4 trials), "Influenza" (3 trials), "Atherosclerotic Cardiovascular Disease" (2 trials), "Familial Hypercholesterolemia" (2 trials) and "Hypercholesterolemia" (2 trials). Many other conditions were trialed in "Knowle House Surgery" in a lesser frequency.

Most popular intervention types in "Knowle House Surgery" are "Drug" (17 trials), "Biological" (2 trials), "Device" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "Pitavastatin" (3 trials), "Tirzepatide" (3 trials), "40 mg Laninamivir Octanoate" (1 trials) and "80 mg Laninamivir Octanoate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Knowle House Surgery" are 19 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Knowle House Surgery". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Knowle House Surgery, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Knowle House Surgery, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".